Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balances, at Beginning of period at Dec. 31, 2022	$ 1,024	$ 390,819	$ (137,875)	$ 253,968
Balances, at Beginning of period, Shares at Dec. 31, 2022	102,397,913
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense		13,979		13,979
Vesting of restricted stock units	$ 3	(3)
Vesting of restricted stock units, shares	288,550
Issuance of common stock under employee stock purchase plan	$ 1	268		$ 269
Issuance of common stock under employee stock purchase plan, shares	82,423			82,423
Exercise of stock options	$ 12	1,862		$ 1,874
Exercise of stock options, shares	1,192,784			1,192,784
Net Income (Loss)			(37,923)	$ (37,923)
Balances, at end of period at Dec. 31, 2023	$ 1,040	406,925	(175,798)	232,167
Balances, at end of period, Shares at Dec. 31, 2023	103,961,670
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense		13,083		13,083
Vesting of restricted stock units	$ 4	(4)
Vesting of restricted stock units, shares	418,260
Issuance of common stock under employee stock purchase plan	$ 1	458		$ 459
Issuance of common stock under employee stock purchase plan, shares	140,046			140,046
Exercise of stock options	$ 12	1,585		$ 1,597
Exercise of stock options, shares	1,191,117			1,191,117
Net Income (Loss)			(41,055)	$ (41,055)
Balances, at end of period at Dec. 31, 2024	$ 1,057	$ 422,047	$ (216,853)	$ 206,251
Balances, at end of period, Shares at Dec. 31, 2024	105,711,093